Keep pulling the thread on Dave Ricks.
Dave Ricks advocates for a "one fair price" model where pharmaceutical companies would set a U.S. price and then be required to offer the drug in other developed nations at a price indexed to that country's GDP per capita.
Eli Lilly's average drug development time is under seven years, which is faster than the industry average of 10 years.
Eli Lilly's Alzheimer's prevention study, which screened over 80,000 people, was the fastest-enrolling Alzheimer's study in history.
Eli Lilly's medical R&D spending is projected to be $14 billion for the current year.
Eli Lilly has a market capitalization of approximately $700 billion.
Eli Lilly is the world's most valuable pharmaceutical company.
The majority of Eli Lilly's business is now derived from its GLP-1 drugs for diabetes and weight loss.
Eli Lilly is selling drugs directly to consumers online through its Lilly Direct platform, bypassing traditional pharmacy middlemen.
Eli Lilly is building an on-premise supercomputer with NVIDIA to run proprietary drug discovery models.
Eli Lilly believes its new on-premise supercomputer, which uses NVIDIA's B300 chipset, is the largest biologically-focused supercomputer and the largest ever built by a pharmaceutical company.
Eli Lilly will spend almost 25% of its sales revenue on R&D this year.
The average cost to develop a new drug is between $3.5 billion and $4 billion, with over 60% of that cost incurred during the final Phase 3 trial.